Merlin G Butler1, Ann M Manzardo, Janice L Forster. 1. University of Kansas Medical Center, Department of Psychiatry and Behavioral Sciences, 3901 Rainbow Boulevard, MS 4015, Kansas City, Kansas 66160, USA. mbutler4@kumc.edu.
Abstract
BACKGROUND: Prader-Willi syndrome (PWS) is a neuro-developmental genetic disorder due to lack of expression of genes inherited from the paternal chromosome 15q11-q13 region with three main genetic subtypes. These include paternal 15q11-q13 deletion (about 70% of cases), maternal uniparental disomy 15 or both 15s from the mother (20-30% of cases), and defects in the imprinting center (1-3%) which controls the expression of imprinted genes in this chromosome region. Clinical manifestations include infantile hypotonia with a poor suck resulting in failure to thrive, short stature, small hands/feet and hypogonadism/hypogenitalism due to growth and other hormone deficiencies, hyperphagia and excessive weight gain with obesity and cognitive and behavioral problems including obsessive compulsions, tantrums and self-injury. The phenotype is likely related to hypothalamic dysfunction. OBJECTIVE: Hyperphagia and obesity with related complications are major causes of morbidity and mortality in PWS requiring accurate diagnosis, appropriate medical management and treatment; the major objective of our report. METHODS AND RESULTS: An extensive review of the literature was undertaken including genetics, clinical and behavioral aspects, and updated health-related information addressing the importance of early diagnosis and treatment of individuals with Prader-Willi syndrome. A searchable, bulleted and formatted list of topics related to this obesity syndrome was provided utilizing a Table of Contents approach for the clinical practitioner. CONCLUSIONS: Physicians and other health care providers can use this review with clinical, genetic and treatment summaries divided into sections that are pertinent in the context of clinical practice. Finally, frequently asked questions by clinicians, families and other interested participants will be addressed.
BACKGROUND:Prader-Willi syndrome (PWS) is a neuro-developmental genetic disorder due to lack of expression of genes inherited from the paternal chromosome 15q11-q13 region with three main genetic subtypes. These include paternal 15q11-q13 deletion (about 70% of cases), maternal uniparental disomy 15 or both 15s from the mother (20-30% of cases), and defects in the imprinting center (1-3%) which controls the expression of imprinted genes in this chromosome region. Clinical manifestations include infantile hypotonia with a poor suck resulting in failure to thrive, short stature, small hands/feet and hypogonadism/hypogenitalism due to growth and other hormone deficiencies, hyperphagia and excessive weight gain with obesity and cognitive and behavioral problems including obsessive compulsions, tantrums and self-injury. The phenotype is likely related to hypothalamic dysfunction. OBJECTIVE:Hyperphagia and obesity with related complications are major causes of morbidity and mortality in PWS requiring accurate diagnosis, appropriate medical management and treatment; the major objective of our report. METHODS AND RESULTS: An extensive review of the literature was undertaken including genetics, clinical and behavioral aspects, and updated health-related information addressing the importance of early diagnosis and treatment of individuals with Prader-Willi syndrome. A searchable, bulleted and formatted list of topics related to this obesity syndrome was provided utilizing a Table of Contents approach for the clinical practitioner. CONCLUSIONS: Physicians and other health care providers can use this review with clinical, genetic and treatment summaries divided into sections that are pertinent in the context of clinical practice. Finally, frequently asked questions by clinicians, families and other interested participants will be addressed.
Authors: Karin Buiting; Stephanie Gross; Christina Lich; Gabriele Gillessen-Kaesbach; Osman el-Maarri; Bernhard Horsthemke Journal: Am J Hum Genet Date: 2003-01-23 Impact factor: 11.025
Authors: Merlin G Butler; Virginia Kimonis; Elisabeth Dykens; June A Gold; Jennifer Miller; Roy Tamura; Daniel J Driscoll Journal: Am J Med Genet A Date: 2017-12-22 Impact factor: 2.802
Authors: Guo-Qing Dong; Yue-Yue Su; Xiao-Ying Qiu; Xi-Yan Lu; Jian-Xu Li; Miao Huang; Xiao-Ping Luo Journal: Zhongguo Dang Dai Er Ke Za Zhi Date: 2020-09
Authors: Preeti Singh; Ranim Mahmoud; June-Anne Gold; Jennifer L Miller; Elizabeth Roof; Roy Tamura; Elisabeth Dykens; Merlin G Butler; Dan J Driscoll; Virginia Kimonis Journal: J Med Genet Date: 2018-05-18 Impact factor: 6.318
Authors: C Mele; A Crinò; D Fintini; S Mai; A Convertino; S Bocchini; P Di Paolo; G Grugni; G Aimaretti; M Scacchi; P Marzullo Journal: J Endocrinol Invest Date: 2020-10-16 Impact factor: 4.256
Authors: Isaac Baldwin; Robin L Shafer; Waheeda A Hossain; Sumedha Gunewardena; Olivia J Veatch; Matthew W Mosconi; Merlin G Butler Journal: Int J Mol Sci Date: 2021-02-07 Impact factor: 5.923